87 related articles for article (PubMed ID: 22534005)
1. Dermatitis associated with cetuximab and radiotherapy: the potential benefit with recombinant human epidermal growth factor and a concern regarding the use of steroids.
Revannasiddaiah S; Thakur P; Gupta M
Oral Oncol; 2013 Mar; 49(3):e3. PubMed ID: 22534005
[No Abstract] [Full Text] [Related]
2. Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy.
Cabezón-Gutiérrez L; Khosravi-Shahi P; Escobar-Álvarez Y
Oral Oncol; 2012 Apr; 48(4):293-7. PubMed ID: 22137799
[TBL] [Abstract][Full Text] [Related]
3. Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required.
Langendijk JA; Oosting SF
Ann Oncol; 2011 Oct; 22(10):2157-9. PubMed ID: 21878428
[No Abstract] [Full Text] [Related]
4. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines.
Bernier J; Russi EG; Homey B; Merlano MC; Mesía R; Peyrade F; Budach W
Ann Oncol; 2011 Oct; 22(10):2191-200. PubMed ID: 21606209
[TBL] [Abstract][Full Text] [Related]
5. More on severe cutaneous reaction with radiotherapy and cetuximab.
Bonner JA; Ang K
N Engl J Med; 2007 Nov; 357(18):1872-3; author reply 1873. PubMed ID: 17978301
[No Abstract] [Full Text] [Related]
6. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.
Bernier J; Bonner J; Vermorken JB; Bensadoun RJ; Dummer R; Giralt J; Kornek G; Hartley A; Mesia R; Robert C; Segaert S; Ang KK
Ann Oncol; 2008 Jan; 19(1):142-9. PubMed ID: 17785763
[TBL] [Abstract][Full Text] [Related]
7. Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.
Russi EG; Bensadoun RJ; Merlano MC; Bourhis J; Ricardi U; Giralt J; Pinto C; Budach W; Corvò R; Lacouture ME; Bernier J
Ann Oncol; 2013 Sep; 24(9):2463-5. PubMed ID: 23897703
[No Abstract] [Full Text] [Related]
8. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
Teoh DC; Rodger S; Say J; Hartley A
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
[No Abstract] [Full Text] [Related]
9. Radiotherapy combined with cetuximab for locally advanced head and neck cancer: results and toxicity.
Acevedo-Henao CM; Valette G; Miglierini P; Lefur E; Pradier O
Cancer Radiother; 2012 Oct; 16(7):601-3. PubMed ID: 23089070
[TBL] [Abstract][Full Text] [Related]
10. Severe desquamation with skin necrosis: a distinct pattern of skin toxicity secondary to head and neck irradiation with concomitant cetuximab.
Billan S; Abdah-Bortnyak R; Kuten A
Isr Med Assoc J; 2008 Mar; 10(3):247. PubMed ID: 18494248
[No Abstract] [Full Text] [Related]
11. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.
Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J
Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918
[TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous reaction during radiation therapy with concurrent cetuximab.
Budach W; Bölke E; Homey B
N Engl J Med; 2007 Aug; 357(5):514-5. PubMed ID: 17671265
[No Abstract] [Full Text] [Related]
13. Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.
Levy AR; Johnston KM; Sambrook J; Donato B; Penrod JR; Corral M; Chasen M
Curr Med Res Opin; 2011 Dec; 27(12):2253-9. PubMed ID: 22017232
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in head and neck cancer.
Haddad RI; Shin DM
N Engl J Med; 2008 Sep; 359(11):1143-54. PubMed ID: 18784104
[No Abstract] [Full Text] [Related]
15. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
[TBL] [Abstract][Full Text] [Related]
16. Severe cutaneous toxicity during concomitant radiotherapy and cetuximab treatment of head and neck cancer.
Vano-Galvan S; de las Heras E; Harto A; Jaen P
Eur J Dermatol; 2008; 18(4):471-2. PubMed ID: 18573734
[No Abstract] [Full Text] [Related]
17. Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press).
Russi EG; Numico G; Merlano MC; Pinto C
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1278; author reply 1278-9. PubMed ID: 21353162
[No Abstract] [Full Text] [Related]
18. Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma.
Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Porceddu SV
Oral Oncol; 2011 Oct; 47(10):984-7. PubMed ID: 21852185
[TBL] [Abstract][Full Text] [Related]
19. Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab.
Bölke E; Gerber PA; Lammering G; Peiper M; Müller-Homey A; Pape H; Giro C; Matuschek C; Bruch-Gerharz D; Hoffmann TK; Gripp S; Homey B; Budach W
Strahlenther Onkol; 2008 Feb; 184(2):105-10. PubMed ID: 18259703
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.
Robert F; Ezekiel MP; Spencer SA; Meredith RF; Bonner JA; Khazaeli MB; Saleh MN; Carey D; LoBuglio AF; Wheeler RH; Cooper MR; Waksal HW
J Clin Oncol; 2001 Jul; 19(13):3234-43. PubMed ID: 11432891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
